CRA-2059 structure
|
Common Name | CRA-2059 | ||
|---|---|---|---|---|
| CAS Number | 256649-36-2 | Molecular Weight | 750.80 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C34H46N12O8 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of CRA-2059CRA-2059 is a highly specific and selective tryptase inhibitor, with a Ki of 620 pM for recombinant human tryptase-β (rHTβ)[1][2]. |
| Name | CRA-2059 |
|---|
| Description | CRA-2059 is a highly specific and selective tryptase inhibitor, with a Ki of 620 pM for recombinant human tryptase-β (rHTβ)[1][2]. |
|---|---|
| Related Catalog | |
| In Vitro | Tryptase is a trypsin-like serine protease found as a major protein component in human mast cell secretory granules. CRA-2059 has the potential for inflammatory bowel disease research[1]. |
| References |
| Molecular Formula | C34H46N12O8 |
|---|---|
| Molecular Weight | 750.80 |
| InChIKey | SDKLWMXBZVGUHI-XPALAHHGSA-N |
| SMILES | NC(N)=Nc1ccc(CNC(=O)N2CCN(C(=O)OC3COC4C(OC(=O)N5CCN(C(=O)NCc6ccc(N=C(N)N)cc6)CC5)COC34)CC2)cc1 |